Michael Siebels

6.9k citations
65 papers · 5.3k · 1 hit paper · h-index 22

Impact in

Papers in

Michael Siebels

61 papers receiving 5.1k citations

Michael Siebels's Hit Papers

Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma 2007 · 3.8k citations
3.8k0+6+12Years since publication10002.0k3.0k

Peers

Michael Siebels
Comparison fields: 5 of 111
  • Pulmonary and Respiratory Medicine 2.8k
  • Cancer Research 1.1k
  • Oncology 1.1k
  • Urology 202
  • Molecular Biology 1.9k
Replace I. Bodrogi with:
I. Bodrogi Hungary
Daniel Castellano Spain
Tomasz Demkow Poland
José A. Karam United States
Jens Bedke Germany
Neeraj Agarwal United States
Elizabeth R. Plimack United States
Christine Théodore France
Xavier García del Muro Spain
Gary R. Hudes United States
Michael Siebels relative to I. Bodrogi Hungary I. Bodrogi's profile →
Citations per field
00.5×1.7×
I. Bodrogi · 1×
Citations per year

Countries citing papers authored by Michael Siebels

Since Specialization
Citations

This map shows the geographic impact of Michael Siebels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Siebels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Siebels more than expected).

Fields of papers citing papers by Michael Siebels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Siebels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Siebels. The network helps show where Michael Siebels may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Siebels, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Siebels Line = papers co-authored together Michael Siebels links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Hit paper breakdown →
20073815
2 2005193
3 2004155
4 200293
5 201092
6 201085
7 200573
8 200559
9 200145
10 200344
11 200238
12 200035
13 200631
14 201030
15 200929
16 200529
17 200528
18 199327
19 200526
20 200923

About Michael Siebels

Michael Siebels is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Oncology and Cancer Research, having authored 65 papers that have together received 5.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (24 papers), Renal and related cancers (10 papers), Cancer Immunotherapy and Biomarkers (7 papers), Bladder and Urothelial Cancer Treatments (7 papers), Cancer Genomics and Diagnostics (6 papers), Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (4 papers) and Vasculitis and related conditions (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.8k citations), Cancer Research (1.1k citations), Oncology (1.1k citations), Urology (202 citations) and Molecular Biology (1.9k citations). Michael Siebels has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Sylvie Négrier, Brian Schwartz, Ronit Simantov, Tim Eisen, E Solska, Minghua Shan, Bernard Escudier, Martin Gore, Cezary Szczylik and Thomas E. Hutson. Their work appears in journals such as World Journal of Urology, British Journal of Urology, Journal of Clinical Oncology, Nephrology Dialysis Transplantation and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact